LVSP Based CRT vs. RVAP Based CRT

NCT05985408 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-08-14

No results posted yet for this study

Summary

To find out whether left ventricular septal pacing (LVSP)-based cardiac resynchronization therapy (CRT) is superior to right ventricular apical pacing (RVAP)-based CRT in patients with failed left bundle branch pacing at the beginning of chronic heart failure.

Conditions

  • Heart Failure
  • Cardiac Resynchronization Therapy
  • Left Ventricular Septal Pacing
  • Right Ventricular Septal Pacing

Interventions

DEVICE

left ventricular septal pacing

For left bundle branch pacing (LBBP) failure cases, use left ventricular septal pacing instead of LBBP; others were same as traditional CRT.

DEVICE

right ventricular apical pacing

For left bundle branch pacing (LBBP) failure cases, use right ventricular apical pacing instead of LBBP; others were same as traditional CRT.

Sponsors & Collaborators

  • Fu Wai Hospital, Beijing, China

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-03-01
Completion
2025-09-01
FDA Device
Yes

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05985408 on ClinicalTrials.gov